Skip to main content
Top
Published in: Journal of Neuro-Oncology 2/2014

01-11-2014 | Clinical Study

Incidence of intracranial germ cell tumors by race in the United States, 1992–2010

Authors: Jenny N. Poynter, Rachel Fonstad, Jakub Tolar, Logan G. Spector, Julie A. Ross

Published in: Journal of Neuro-Oncology | Issue 2/2014

Login to get access

Abstract

Little is known about the etiology of intracranial germ cell tumors (iGCTs), although international incidence data suggest that the highest incidence rates occur in Asian countries. In this analysis, we used 1992–2010 data from the National Cancer Institute’s Surveillance, Epidemiology and End Results (SEER) Program to determine whether rates of iGCT were also high in Asian/Pacific Islanders living in the United States. Frequencies, incidence rates and survival rates were evaluated for the entire cohort and for demographic subgroups based on sex, age category (0–9 and 10–29 years), race (white, black, and Asian/Pacific Islander), and tumor location (pineal gland vs. other) as sample size permitted. Analyses were conducted using SEER*Stat 8.1.2. We observed a significantly higher incidence rate of iGCT in Asian/Pacific Islanders compared with whites (RR = 2.05, 95 % CI 1.57–2.64, RR = 3.04, 95 % CI 1.75–5.12 for males and females, respectively) in the 10–29 year age group. This difference was observed for tumors located both in the pineal gland and for tumors in other locations. Five-year relative survival differed by demographic and tumor characteristics, although these differences were not observed in comparisons limited to cases treated with radiation. Increased incidence rates of iGCT in individuals of Asian descent in the SEER registry are in agreement with data from the International Agency for Research on Cancer, where Japan and Singapore were among the countries with highest incidence. The increased incidence in individuals of Asian ancestry in the United States suggests that underlying genetic susceptibility may play a role in the etiology of iGCT.
Literature
2.
go back to reference Oosterhuis JW, Stoop H, Honecker F, Looijenga LH (2007) Why human extragonadal germ cell tumours occur in the midline of the body: old concepts, new perspectives. Int J Androl 30: 256–263; discussion 263–254 doi: 10.1111/j.1365-2605.2007.00793.x Oosterhuis JW, Stoop H, Honecker F, Looijenga LH (2007) Why human extragonadal germ cell tumours occur in the midline of the body: old concepts, new perspectives. Int J Androl 30: 256–263; discussion 263–254 doi: 10.​1111/​j.​1365-2605.​2007.​00793.​x
3.
go back to reference Arora RS, Alston RD, Eden TO, Geraci M, Birch JM (2012) Comparative incidence patterns and trends of gonadal and extragonadal germ cell tumors in England, 1979 to 2003. Cancer 118:4290–4297. doi:10.1002/cncr.27403 PubMedCrossRef Arora RS, Alston RD, Eden TO, Geraci M, Birch JM (2012) Comparative incidence patterns and trends of gonadal and extragonadal germ cell tumors in England, 1979 to 2003. Cancer 118:4290–4297. doi:10.​1002/​cncr.​27403 PubMedCrossRef
5.
6.
go back to reference McCarthy BJ, Shibui S, Kayama T, Miyaoka E, Narita Y, Murakami M, Matsuda A, Matsuda T, Sobue T, Palis BE, Dolecek TA, Kruchko C, Engelhard HH, Villano JL (2012) Primary CNS germ cell tumors in Japan and the United States: an analysis of 4 tumor registries. Neuro Oncol 14:1194–1200. doi:10.1093/neuonc/nos155 PubMedCrossRefPubMedCentral McCarthy BJ, Shibui S, Kayama T, Miyaoka E, Narita Y, Murakami M, Matsuda A, Matsuda T, Sobue T, Palis BE, Dolecek TA, Kruchko C, Engelhard HH, Villano JL (2012) Primary CNS germ cell tumors in Japan and the United States: an analysis of 4 tumor registries. Neuro Oncol 14:1194–1200. doi:10.​1093/​neuonc/​nos155 PubMedCrossRefPubMedCentral
9.
go back to reference Parkin DM, Kramarova E, Draper GJ, Masuyer E, Michaelis J, Neglia J, Qureshi S, Stiller CA (eds) (1998) International incidence of childhood cancer. International Agency for Research on Cancer. World Health Organization, Lyon Parkin DM, Kramarova E, Draper GJ, Masuyer E, Michaelis J, Neglia J, Qureshi S, Stiller CA (eds) (1998) International incidence of childhood cancer. International Agency for Research on Cancer. World Health Organization, Lyon
11.
go back to reference Surveillance, epidemiology, and end results (SEER) program. SEER*Stat Database: incidence—SEER 14 Regs Research Data, Nov 2011 Sub (1992–2010). Bethesda, Md: National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2013, based on the November 2012 submission. http://www.seer.cancer.gov Surveillance, epidemiology, and end results (SEER) program. SEER*Stat Database: incidence—SEER 14 Regs Research Data, Nov 2011 Sub (1992–2010). Bethesda, Md: National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2013, based on the November 2012 submission. http://​www.​seer.​cancer.​gov
15.
go back to reference Zippin C, Lum D, Hankey BF (1995) Completeness of hospital cancer case reporting from the SEER Program of the National Cancer Institute. Cancer 76:2343–2350PubMedCrossRef Zippin C, Lum D, Hankey BF (1995) Completeness of hospital cancer case reporting from the SEER Program of the National Cancer Institute. Cancer 76:2343–2350PubMedCrossRef
16.
go back to reference World Health Organization (2000) International classification of diseases for oncology, 3rd edn. WHO, Geneva World Health Organization (2000) International classification of diseases for oncology, 3rd edn. WHO, Geneva
19.
go back to reference Ederer F, Axtell LM, Cutler SJ (1961) The relative survival rate: a statistical methodology. Natl Cancer Inst Monogr 6:101–121PubMed Ederer F, Axtell LM, Cutler SJ (1961) The relative survival rate: a statistical methodology. Natl Cancer Inst Monogr 6:101–121PubMed
23.
go back to reference Bauchet L, Rigau V, Mathieu-Daude H, Fabbro-Peray P, Palenzuela G, Figarella-Branger D, Moritz J, Puget S, Bauchet F, Pallusseau L, Duffau H, Coubes P, Tretarre B, Labrousse F, Dhellemmes P (2009) Clinical epidemiology for childhood primary central nervous system tumors. J Neurooncol 92:87–98. doi:10.1007/s11060-008-9740-0 PubMedCrossRef Bauchet L, Rigau V, Mathieu-Daude H, Fabbro-Peray P, Palenzuela G, Figarella-Branger D, Moritz J, Puget S, Bauchet F, Pallusseau L, Duffau H, Coubes P, Tretarre B, Labrousse F, Dhellemmes P (2009) Clinical epidemiology for childhood primary central nervous system tumors. J Neurooncol 92:87–98. doi:10.​1007/​s11060-008-9740-0 PubMedCrossRef
24.
go back to reference Wong TT, Ho DM, Chang KP, Yen SH, Guo WY, Chang FC, Liang ML, Pan HC, Chung WY (2005) Primary pediatric brain tumors: statistics of Taipei VGH, Taiwan (1975-2004). Cancer 104:2156–2167. doi:10.1002/cncr.21430 PubMedCrossRef Wong TT, Ho DM, Chang KP, Yen SH, Guo WY, Chang FC, Liang ML, Pan HC, Chung WY (2005) Primary pediatric brain tumors: statistics of Taipei VGH, Taiwan (1975-2004). Cancer 104:2156–2167. doi:10.​1002/​cncr.​21430 PubMedCrossRef
26.
go back to reference Ducore JM, Parikh-Patel A, Gold EB (2004) Cancer occurrence in Southeast Asian children in California. J Pediatr Hematol Oncol 26:613–618PubMedCrossRef Ducore JM, Parikh-Patel A, Gold EB (2004) Cancer occurrence in Southeast Asian children in California. J Pediatr Hematol Oncol 26:613–618PubMedCrossRef
27.
go back to reference Motta PM, Nottola SA, Makabe S (1997) Natural history of the female germ cell from its origin to full maturation through prenatal ovarian development. Eur J Obstet Gynecol Reprod Biol 75:5–10PubMedCrossRef Motta PM, Nottola SA, Makabe S (1997) Natural history of the female germ cell from its origin to full maturation through prenatal ovarian development. Eur J Obstet Gynecol Reprod Biol 75:5–10PubMedCrossRef
28.
go back to reference Moller H, Evans H (2003) Epidemiology of gonadal germ cell cancer in males and females. Apmis 111: 43–46; discussion 46–48 Moller H, Evans H (2003) Epidemiology of gonadal germ cell cancer in males and females. Apmis 111: 43–46; discussion 46–48
29.
go back to reference Straif K, Baan R, Grosse Y, Secretan B, El Ghissassi F, Bouvard V, Altieri A, Benbrahim-Tallaa L, Cogliano V (2007) Carcinogenicity of shift-work, painting, and fire-fighting. Lancet Oncol 8:1065–1066PubMedCrossRef Straif K, Baan R, Grosse Y, Secretan B, El Ghissassi F, Bouvard V, Altieri A, Benbrahim-Tallaa L, Cogliano V (2007) Carcinogenicity of shift-work, painting, and fire-fighting. Lancet Oncol 8:1065–1066PubMedCrossRef
33.
34.
go back to reference Cohen HN, Hay ID, Annesley TM, Beastall GH, Wallace AM, Spooner R, Thomson JA, Eastwold P, Klee GG (1982) Serum immunoreactive melatonin in boys with delayed puberty. Clin Endocrinol 17:517–521CrossRef Cohen HN, Hay ID, Annesley TM, Beastall GH, Wallace AM, Spooner R, Thomson JA, Eastwold P, Klee GG (1982) Serum immunoreactive melatonin in boys with delayed puberty. Clin Endocrinol 17:517–521CrossRef
35.
go back to reference Molina-Carballo A, Munoz-Hoyos A, Martin-Garcia JA, Uberos-Fernandez J, Rodriguez-Cabezas T, Acuna-Castroviejo D (1996) 5-Methoxytryptophol and melatonin in children: differences due to age and sex. J Pineal Res 21:73–79PubMedCrossRef Molina-Carballo A, Munoz-Hoyos A, Martin-Garcia JA, Uberos-Fernandez J, Rodriguez-Cabezas T, Acuna-Castroviejo D (1996) 5-Methoxytryptophol and melatonin in children: differences due to age and sex. J Pineal Res 21:73–79PubMedCrossRef
39.
go back to reference Dalmau J, Gleichman AJ, Hughes EG, Rossi JE, Peng X, Lai M, Dessain SK, Rosenfeld MR, Balice-Gordon R, Lynch DR (2008) Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol 7:1091–1098PubMedCrossRefPubMedCentral Dalmau J, Gleichman AJ, Hughes EG, Rossi JE, Peng X, Lai M, Dessain SK, Rosenfeld MR, Balice-Gordon R, Lynch DR (2008) Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol 7:1091–1098PubMedCrossRefPubMedCentral
40.
go back to reference Florance NR, Davis RL, Lam C, Szperka C, Zhou L, Ahmad S, Campen CJ, Moss H, Peter N, Gleichman AJ, Glaser CA, Lynch DR, Rosenfeld MR, Dalmau J (2009) Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis in children and adolescents. Ann Neurol 66:11–18. doi:10.1002/ana.21756 PubMedCrossRefPubMedCentral Florance NR, Davis RL, Lam C, Szperka C, Zhou L, Ahmad S, Campen CJ, Moss H, Peter N, Gleichman AJ, Glaser CA, Lynch DR, Rosenfeld MR, Dalmau J (2009) Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis in children and adolescents. Ann Neurol 66:11–18. doi:10.​1002/​ana.​21756 PubMedCrossRefPubMedCentral
41.
go back to reference Irani SR, Bera K, Waters P, Zuliani L, Maxwell S, Zandi MS, Friese MA, Galea I, Kullmann DM, Beeson D, Lang B, Bien CG, Vincent A (2010) N-methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes. Brain 133:1655–1667. doi:10.1093/brain/awq113 PubMedCrossRefPubMedCentral Irani SR, Bera K, Waters P, Zuliani L, Maxwell S, Zandi MS, Friese MA, Galea I, Kullmann DM, Beeson D, Lang B, Bien CG, Vincent A (2010) N-methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes. Brain 133:1655–1667. doi:10.​1093/​brain/​awq113 PubMedCrossRefPubMedCentral
42.
go back to reference Luca N, Daengsuwan T, Dalmau J, Jones K, deVeber G, Kobayashi J, Laxer RM, Benseler SM (2011) Anti-N-methyl-D-aspartate receptor encephalitis: a newly recognized inflammatory brain disease in children. Arthritis Rheum 63:2516–2522. doi:10.1002/art.30437 PubMedCrossRefPubMedCentral Luca N, Daengsuwan T, Dalmau J, Jones K, deVeber G, Kobayashi J, Laxer RM, Benseler SM (2011) Anti-N-methyl-D-aspartate receptor encephalitis: a newly recognized inflammatory brain disease in children. Arthritis Rheum 63:2516–2522. doi:10.​1002/​art.​30437 PubMedCrossRefPubMedCentral
44.
go back to reference Dalmau J, Tuzun E, Wu HY, Masjuan J, Rossi JE, Voloschin A, Baehring JM, Shimazaki H, Koide R, King D, Mason W, Sansing LH, Dichter MA, Rosenfeld MR, Lynch DR (2007) Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol 61:25–36. doi:10.1002/ana.21050 PubMedCrossRefPubMedCentral Dalmau J, Tuzun E, Wu HY, Masjuan J, Rossi JE, Voloschin A, Baehring JM, Shimazaki H, Koide R, King D, Mason W, Sansing LH, Dichter MA, Rosenfeld MR, Lynch DR (2007) Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol 61:25–36. doi:10.​1002/​ana.​21050 PubMedCrossRefPubMedCentral
45.
go back to reference Lo JW, Leung EY, Ng BL, Fu MH, Yip KK, Chan RT, Chang CM (2010) Anti-N-methyl-D-aspartate receptor encephalitis in a young woman with an ovarian tumour. Hong Kong Med J 16:313–316PubMed Lo JW, Leung EY, Ng BL, Fu MH, Yip KK, Chan RT, Chang CM (2010) Anti-N-methyl-D-aspartate receptor encephalitis in a young woman with an ovarian tumour. Hong Kong Med J 16:313–316PubMed
47.
go back to reference Dabner M, McCluggage WG, Bundell C, Carr A, Leung Y, Sharma R, Stewart CJ (2012) Ovarian teratoma associated with anti-N-methyl D-aspartate receptor encephalitis: a report of 5 cases documenting prominent intratumoral lymphoid infiltrates. Int J Gynecol Pathol 31:429–437. doi:10.1097/PGP.0b013e31824a1de2 PubMedCrossRef Dabner M, McCluggage WG, Bundell C, Carr A, Leung Y, Sharma R, Stewart CJ (2012) Ovarian teratoma associated with anti-N-methyl D-aspartate receptor encephalitis: a report of 5 cases documenting prominent intratumoral lymphoid infiltrates. Int J Gynecol Pathol 31:429–437. doi:10.​1097/​PGP.​0b013e31824a1de2​ PubMedCrossRef
48.
49.
go back to reference Gable MS, Sheriff H, Dalmau J, Tilley DH, Glaser CA (2012) The frequency of autoimmune N-methyl-D-aspartate receptor encephalitis surpasses that of individual viral etiologies in young individuals enrolled in the California Encephalitis Project. Clin Infect Dis 54:899–904. doi:10.1093/cid/cir1038 PubMedCrossRefPubMedCentral Gable MS, Sheriff H, Dalmau J, Tilley DH, Glaser CA (2012) The frequency of autoimmune N-methyl-D-aspartate receptor encephalitis surpasses that of individual viral etiologies in young individuals enrolled in the California Encephalitis Project. Clin Infect Dis 54:899–904. doi:10.​1093/​cid/​cir1038 PubMedCrossRefPubMedCentral
55.
go back to reference Bamberg M, Kortmann RD, Calaminus G, Becker G, Meisner C, Harms D, Gobel U (1999) Radiation therapy for intracranial germinoma: results of the German cooperative prospective trials MAKEI 83/86/89. J Clin Oncol 17:2585–2592PubMed Bamberg M, Kortmann RD, Calaminus G, Becker G, Meisner C, Harms D, Gobel U (1999) Radiation therapy for intracranial germinoma: results of the German cooperative prospective trials MAKEI 83/86/89. J Clin Oncol 17:2585–2592PubMed
57.
go back to reference Merrill RM, Dearden KA (2004) How representative are the surveillance, epidemiology, and end results (SEER) program cancer data of the United States? Cancer Causes Control 15:1027–1034PubMedCrossRef Merrill RM, Dearden KA (2004) How representative are the surveillance, epidemiology, and end results (SEER) program cancer data of the United States? Cancer Causes Control 15:1027–1034PubMedCrossRef
Metadata
Title
Incidence of intracranial germ cell tumors by race in the United States, 1992–2010
Authors
Jenny N. Poynter
Rachel Fonstad
Jakub Tolar
Logan G. Spector
Julie A. Ross
Publication date
01-11-2014
Publisher
Springer US
Published in
Journal of Neuro-Oncology / Issue 2/2014
Print ISSN: 0167-594X
Electronic ISSN: 1573-7373
DOI
https://doi.org/10.1007/s11060-014-1562-7

Other articles of this Issue 2/2014

Journal of Neuro-Oncology 2/2014 Go to the issue